Newborns infected with herpes simplex virus (HSV) can be appropriately treated with acyclovir, a drug typically prescribed to adults for the treatment of HSV infections.
A novel, synthetic DNA vaccine developed at the Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to become a global emerging viral threat.
Researchers of the University of Barcelona (UB) have analyzed, with massive sequencing techniques for the first time, the evolution of the hepatitis A virus with samples from patients.
Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of immune cells that plays an important role in the early fight against dengue virus infection.
Vaccines have saved millions of lives, but nobody likes getting a shot. That's why scientists are trying to develop oral vaccines for infectious diseases. But to be effective, the vaccine must survive digestion and reach immune cells within the intestinal wall.
Mechanical engineers from the Korea Advanced Institute of Science and Technology recently developed a microchip antibiotic testing platform that takes only six to seven hours to determine the appropriate medication.
Serological group B streptococci (GBS) are common bacteria, which usually remain unnoticed. This is also the case for the almost 20 percent of pregnant women with vaginal or anal colonization of GBS.
Beatrice H. Hahn, MD, a professor of medicine and microbiology in the Perelman School of Medicine at the University of Pennsylvania, and her colleagues have been studying the origin of HIV-1 in non-human primates for decades.
During the Zika virus outbreak of 2015-16, public health officials scrambled to contain the epidemic and curb the pathogen's devastating effects on pregnant women. At the same time, scientists around the globe tried to understand the genetics of this mysterious virus.
The objective of this study by Jo, et al.